Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Zosano Pharma (ZSAN) stocks

Learn how to easily invest in Zosano Pharma stocks.

Zosano Pharma is a biotechnology business based in the US. Zosano Pharma stocks (ZSAN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.845 – an increase of 3.45% over the previous week. Zosano Pharma employs 40 staff and has a trailing 12-month revenue of around $659,000.

How to buy Zosano Pharma stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ZSAN. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners


National Bank Direct Brokerage

  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge

  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Zosano Pharma stock price (NASDAQ:ZSAN)

Use our graph to track the performance of ZSAN stocks over time.

Zosano Pharma shares at a glance

Information last updated 2022-07-31.
Latest market close$0.30
52-week range$0.75 - $2.17
50-day moving average $1.38
200-day moving average $0.92
Wall St. target price$21.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-15.69

Buy Zosano Pharma stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
National Bank Direct Brokerage
Finder Rating:
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
CIBC Investor's Edge
Finder Rating:
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.

Is it a good time to buy Zosano Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Zosano Pharma price performance over time

Historical closes compared with the close of $0.3 from 2022-07-08

1 week (2023-05-17) N/A
1 month (2023-04-24) N/A
3 months (2023-02-24) N/A
6 months (2022-11-24) N/A
1 year (2022-05-27) -84.69%
2 years (2021-05-28) -62.50%
3 years (2020-05-28) 1
5 years (2018-05-25) 3.91
[/expander_content] [/expander]

Zosano Pharma financials

Revenue TTM $659,000
Gross profit TTM $-20,985,000
Return on assets TTM -41.86%
Return on equity TTM -192.97%
Profit margin 0%
Book value $2.87
Market capitalisation $2.7 million

TTM: trailing 12 months

Zosano Pharma share dividends

We're not expecting Zosano Pharma to pay a dividend over the next 12 months.

Have Zosano Pharma's shares ever split?

Zosano Pharma's shares were split on a 1:35 basis on 12 April 2022. So if you had owned 35 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Zosano Pharma shares – just the quantity. However, indirectly, the new 3400% higher share price could have impacted the market appetite for Zosano Pharma shares which in turn could have impacted Zosano Pharma's share price.

Zosano Pharma share price volatility

Over the last 12 months, Zosano Pharma's shares have ranged in value from as little as $0.75 up to $2.17. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Zosano Pharma's is 3.2854. This would suggest that Zosano Pharma's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Zosano Pharma overview

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U. S. Bankruptcy Court for the District of Delaware. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site